185 In the index

KPV KPV

A small peptide studied in animals and lab dishes for calming inflammation, particularly in the gut. It has never been tested in human clinical trials, so its real-world evidence base is limited to lab research.

Also known as Lysine-proline-valine

Effects Heal

Routes Oral Subcutaneous Topical

Legal status Research chemical

WADA Not listed

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 200-500 mcg/day

Reported range 200-1000 mcg/day

Route Subcutaneous injection or oral

Frequency Once or twice daily

Duration 4-8 week course (unregulated use)

A fragment of alpha-MSH marketed for gut/skin anti-inflammatory effects; no completed human clinical trials, sold only as a research chemical.

Where this comes from Animal/in-vitro studies only; user-reported/research-chemical vendor literature

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.